Prevention of Acute Kidney Injury in Patients With NSTEMI
Stopped Lower than expected study enrolment rate. New strategic considerations.
Conditions
- Non-ST Elevation Myocardial Infarction (NSTEMI)
Interventions
- DRUG: conestat alfa or placebo
Sponsor
Pharming Technologies B.V.